Colin Bristow, UBS managing director, joins Fast Money to discuss Pfizers weight-loss drug. For access to live and exclusive video from CNBC subscribe







Efficacy of Pfizer's weight-loss drug 'inferior' to others on the market, says UBS's Colin Bristow [nr_8IgcUVzU]

Efficacy of Pfizer's weight-loss drug 'inferior' to others on the market, says UBS's Colin Bristow [nr_8IgcUVzU]

| 1h 28m 28s | Video has closed captioning.

Colin Bristow, UBS managing director, joins 'Fast Money' to discuss Pfizer's weight-loss drug. For access to live and exclusive video from CNBC subscribe to CNBC PRO: » Subscribe to CNBC TV: » Subscribe to CNBC: Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide. Connect with CNBC News Online Get the latest news: Follow CNBC on LinkedIn: Follow CNBC News on Facebook: Follow CNBC News on Twitter: Follow CNBC News on Instagram: #CNBC #CNBCTV  #weight loss oral medication #keto detox pills reviews #keto fusion gummies reviews #keto breeze gummies

Aired: January 05, 2025

Rating: TV-14

Buy Now:

Problems Playing Video? | Closed Captioning

Learn About Midwifery Today

Blog

Learn About Midwifery Today

Read the Modern Day Midwives Blog and learn more about our bloggers, all experienced midwives.

Read now